EULAR 2025 - Day 5 podcast
Jun 16, 2025•29 min•Ep. 1340
Episode description
Biologic Switching in PsA Decoding Difficult to Treat PsA Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact GLP 1 Receptor Agonists in axSpA Patients Jekyll and Hyde: which RA-ILD is it? RA treatment: A Constant State of Evolution
For the best experience, listen in Metacast app for iOS or Android
